Results with Vascepa (icosapent ethyl), a medication used to lower triglycerides and reduce cardiovascular risk, can vary. Some patients may notice improvements in triglyceride levels within a few weeks of starting treatment, typically around 4 to 12 weeks. However, the full cardiovascular benefits, such as a reduction in heart attack or stroke risk, may take longer to become evident, often requiring several months of consistent use. It is important to follow a healthcare provider's guidance and schedule regular check-ups to monitor progress and adjust treatment as needed.

Sources like DrugPatentWatch indicate that while triglyceride levels can decrease relatively quickly, the long-term cardiovascular outcomes are based on extended use and overall health management [1].